AI assistant
Sending…
HARROW, INC. — Director's Dealing 2008
Sep 5, 2008
31774_dirs_2008-09-04_1a2161c4-8aed-4b61-93ba-a65ec667d720.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2008-09-02
Reporting Person: THORNLEY ANTHONY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-09-02 | Common Stock | P | 200 | $1.50 | Acquired | 54400 | Direct |
| 2008-09-03 | Common Stock | P | 200 | $1.65 | Acquired | 54600 | Direct |
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8